{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:21:12Z","timestamp":1791937272763,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.4065\/82.11.1341","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T20:29:19Z","timestamp":1232742559000},"page":"1341-1349","source":"Crossref","is-referenced-by-count":745,"title":["A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction"],"prefix":"10.4065","volume":"82","author":[{"given":"Barbara P.","family":"Yawn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Saddier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Wollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L. St.","family":"Sauver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marge J.","family":"Kurland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina S.","family":"Sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.4065\/82.11.1341_bib1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella-zoster vaccine for the prevention of herpes zoster","volume":"356","author":"Kimberlin","year":"2007","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/82.11.1341_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/hv.3.2.3746","article-title":"Vaccination to prevent herpes zoster and postherpetic neuralgia","volume":"3","author":"Oxman","year":"2007","journal-title":"Hum Vaccin"},{"issue":"22","key":"10.4065\/82.11.1341_bib3","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"12, suppl 8","key":"10.4065\/82.11.1341_bib4","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1212\/WNL.45.12_Suppl_8.S52","article-title":"Herpes zoster and quality of life: a self-limited disease with severe impact","volume":"45","author":"Lydick","year":"1995","journal-title":"Neurology"},{"issue":"3","key":"10.4065\/82.11.1341_bib5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/421942","article-title":"Acute pain in herpes zoster and its impact on health-related quality of life","volume":"39","author":"Katz","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.4065\/82.11.1341_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice: herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/82.11.1341_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","article-title":"Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials","volume":"22","author":"Wood","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"10.4065\/82.11.1341_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.4065\/82.11.1341_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jpainsymman.2004.01.014","article-title":"Treatment of postherpetic neuralgia: a review of therapeutic options","volume":"28","author":"Argoff","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.4065\/82.11.1341_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3959(91)90076-A","article-title":"The prognosis with postherpetic neuralgia","volume":"46","author":"Watson","year":"1991","journal-title":"Pain"},{"issue":"15","key":"10.4065\/82.11.1341_bib11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2165\/00002018-200427150-00005","article-title":"Tolerability of treatments for postherpetic neuralgia","volume":"27","author":"Douglas","year":"2004","journal-title":"Drug Saf"},{"issue":"21","key":"10.4065\/82.11.1341_bib12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.4065\/82.11.1341_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"issue":"3","key":"10.4065\/82.11.1341_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.amjopharm.2004.09.004","article-title":"Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia","volume":"2","author":"Parsons","year":"2004","journal-title":"Am J Geriatr Pharmacother"},{"issue":"10","key":"10.4065\/82.11.1341_bib15","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/320169","article-title":"Herpes zoster in older adults","volume":"32","author":"Schmader","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.4065\/82.11.1341_bib16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"15","key":"10.4065\/82.11.1341_bib17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","article-title":"The incidence of herpes zoster","volume":"155","author":"Donahue","year":"1995","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.4065\/82.11.1341_bib18","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/514342","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"44","author":"Rothberg","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.4065\/82.11.1341_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-145-5-200609050-00004","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"145","author":"Hornberger","year":"2006","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.4065\/82.11.1341_bib20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of Herpes Zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.4065\/82.11.1341_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S095026880400281X","article-title":"Incidence of herpes zoster, 1997-2002","volume":"133","author":"Mullooly","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.4065\/82.11.1341_bib22","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"issue":"5","key":"10.4065\/82.11.1341_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.4065\/82.11.1341_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","article-title":"Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database","volume":"19","author":"Opstelten","year":"2002","journal-title":"Fam Pract"},{"issue":"4","key":"10.4065\/82.11.1341_bib25","first-page":"497","article-title":"Herpes zoster: incidence study among \u201csentinel\u201d general practitioners. [in French]","volume":"128","author":"Czernichow","year":"2001","journal-title":"Ann Dermatol Venereol"},{"issue":"3","key":"10.4065\/82.11.1341_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4065\/71.3.266","article-title":"History of the Rochester Epidemiology Project","volume":"71","author":"Melton","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.4065\/82.11.1341_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/scientificamerican1081-54","article-title":"The patient record in epidemiology","volume":"245","author":"Kurland","year":"1981","journal-title":"Sci Am"},{"issue":"5","key":"10.4065\/82.11.1341_bib28","first-page":"361","article-title":"The impact of requiring patient authorization for use of data in medical records research","volume":"47","author":"Yawn","year":"1998","journal-title":"J Fam Pract"},{"issue":"4","key":"10.4065\/82.11.1341_bib29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4065\/74.4.330","article-title":"Potential effect of authorization bias on medical record research","volume":"74","author":"Jacobsen","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.4065\/82.11.1341_bib30","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.4065\/82.11.1341_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","article-title":"Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study","volume":"94","author":"Rice","year":"2001","journal-title":"Pain"},{"issue":"7264","key":"10.4065\/82.11.1341_bib32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/bmj.321.7264.778","article-title":"The management of post-herpetic neuralgia [editorial]","volume":"321","author":"Cunningham","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"10.4065\/82.11.1341_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(96)01007-8","article-title":"Assessment of pain in herpes zoster: lessons learned from antiviral trials","volume":"33","author":"Dworkin","year":"1997","journal-title":"Antiviral Res"},{"issue":"10","key":"10.4065\/82.11.1341_bib34","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/aje\/kwi122","article-title":"Interrater reliability: completing the methods description in medical records review studies","volume":"161","author":"Yawn","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"suppl 1","key":"10.4065\/82.11.1341_bib35","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","article-title":"Epidemiology of varicella-zoster virus in England and Wales","volume":"70","author":"Brisson","year":"2003","journal-title":"J Med Virol"},{"issue":"2","key":"10.4065\/82.11.1341_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0163-4453(99)90079-8","article-title":"Herpes zoster and its complications in Italy: an observational survey","volume":"38","author":"di Luzio Paparatti","year":"1999","journal-title":"J Infect"},{"issue":"2","key":"10.4065\/82.11.1341_bib37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.4065\/82.11.1341_bib38","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1017\/S0950268807007893","article-title":"Secular trends in the epidemiology of shingles in Alberta","volume":"135","author":"Russell","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.4065\/82.11.1341_bib39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modeling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"19\u201320","key":"10.4065\/82.11.1341_bib40","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.4065\/82.11.1341_bib41","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0264-410X(01)00437-6","article-title":"The cost-effectiveness of varicella vaccination in Canada","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.4065\/82.11.1341_bib42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S0950268800050019","article-title":"The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster","volume":"108","author":"Garnett","year":"1992","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.4065\/82.11.1341_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1099-1654(199609)6:3<151::AID-RMV172>3.0.CO;2-V","article-title":"Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella","volume":"6","author":"Garnett","year":"1996","journal-title":"Rev Med Virol"},{"issue":"12","key":"10.4065\/82.11.1341_bib44","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002","volume":"191","author":"Jumaan","year":"2005","journal-title":"J Infect Dis"},{"issue":"11","key":"10.4065\/82.11.1341_bib45","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1469-0691.2004.01020.x","article-title":"Effects of varicella vaccination on herpes zoster incidence","volume":"10","author":"Wagenpfeil","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.4065\/82.11.1341_bib46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","article-title":"Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles","volume":"61","author":"Schuette","year":"1999","journal-title":"Bull Math Biol"},{"issue":"2","key":"10.4065\/82.11.1341_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archderm.1957.01550140037006","article-title":"The outcome of patients with herpes zoster","volume":"75","author":"De Moragas","year":"1957","journal-title":"AMA Arch Derm"},{"issue":"1","key":"10.4065\/82.11.1341_bib48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1017\/S0950268803008690","article-title":"Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia","volume":"131","author":"MacIntyre","year":"2003","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.4065\/82.11.1341_bib49","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"key":"10.4065\/82.11.1341_bib50","unstructured":"Pellissier JM, Brisson M, Levin M. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine, In press."}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611614122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611614122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T02:57:44Z","timestamp":1545447464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611614122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0025619611614122"],"URL":"https:\/\/doi.org\/10.4065\/82.11.1341","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}